1. Restriction of SARS-CoV-2 replication in the human placenta
- Author
-
Kazuhide Takada, Sayaka Shimodai-Yamada, Mayumi Suzuki, Quang Duy Trinh, Chika Takano, Kaori Kawakami, Mikiko Asai-Sato, Atsushi Komatsu, Aya Okahashi, Nobuhiko Nagano, Toshiya Misawa, Kyohei Yamaguchi, Tadaki Suzuki, Kei Kawana, Ichiro Morioka, Hideto Yamada, Satoshi Hayakawa, Hiroyuki Hao, and Shihoko Komine-Aizawa
- Subjects
Reproductive Medicine ,Pregnancy ,SARS-CoV-2 ,Placenta ,Spike Glycoprotein, Coronavirus ,Obstetrics and Gynecology ,COVID-19 ,Humans ,Female ,Pregnancy Complications, Infectious ,Infectious Disease Transmission, Vertical ,Developmental Biology - Abstract
Although SARS-CoV-2 can infect human placental tissue, vertical transmission is rare. Therefore, the placenta may function as a barrier to inhibit viral transmission to the foetus, though the mechanisms remain unclear. In this study, we confirmed the presence of the SARS-CoV-2 genome in human placental tissue by in situ hybridization with antisense probes targeting the spike protein; tissue staining was much lower when using sense probes for the spike protein. To the best of our knowledge, this is the first evidence directly indicating inefficient viral replication in the SARS-CoV-2-infected placenta. Additional studies are required to reveal the detailed mechanisms.
- Published
- 2022